AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
Aims: Over the past few years, AI has been considered as potential important area for improving drug development and in the current urgent need to fight the global COVID-19 pandemic new technologies are even more in focus with the hope to speed up this process. The purpose of our study was to identi...
Saved in:
Main Authors: | Marcin Delijewski (Author), Jacek Haneczok (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
by: Christopher A Rice, et al.
Published: (2020) -
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
by: Rosalba Florio, et al.
Published: (2021) -
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023) -
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
by: Melissa Alegría-Arcos, et al.
Published: (2022) -
Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds.
by: Jair L Siqueira-Neto, et al.
Published: (2010)